Paper6684
Quipazine: a serotoninergic hyperthermic agent in the rabbit.
Quock RM and 2 others. J Pharm Pharmacol, 1976. Cited by 28 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Quipazine: a serotoninergic hyperthermic agent in the rabbit. Papers, record 6684. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6684
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Body Temperature | Major topic |
| Quinolines | Major topic |
| Serotonin | Major topic |
| Animals | |
| Depression, Chemical | |
| Dopamine | |
| Drug Interactions | |
| Male | |
| Piperazines | |
| Rabbits | |
| Time Factors |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7,130,970 | The comparative roles of dopaminergic and serotonergic mechanisms in mediating quipazine induced locomotor activity. | J Neural Transm | 1982 | https://conductscience.org/library/papers/7130970 | PubMed |
| 6,770,410 | Evidence for the role of noradrenaline in some effects of quipazine. | Psychopharmacology (Berl) | 1980 | https://conductscience.org/library/papers/6770410 | PubMed |
| 6,619,829 | The comparative roles of dopaminergic and serotonergic mechanisms in mediating quipazine induced increases in locomotor activity. | J Neural Transm | 1983 | https://conductscience.org/library/papers/6619829 | PubMed |
| 6,275,275 | Antagonistic properties of quipazine at presynaptic serotonin receptors and alpha-adrenoceptors in rat brain cortex slices. | Naunyn Schmiedebergs Arch Pharmacol | 1981 | https://conductscience.org/library/papers/6275275 | PubMed |
| 6,250,088 | Enhanced behavioural, electrocortical and hyperthermic effects of serotonin-like agents after impairment of serotonin transmission in fowl brain. | Naunyn Schmiedebergs Arch Pharmacol | 1980 | https://conductscience.org/library/papers/6250088 | PubMed |
| 6,168,922 | Further evidence for negative feedback control of serotonin release in the central nervous system. | Naunyn Schmiedebergs Arch Pharmacol | 1981 | https://conductscience.org/library/papers/6168922 | PubMed |
| 925,686 | The influence of bromocriptine on serotonin neurons. | J Neural Transm | 1977 | https://conductscience.org/library/papers/925686 | PubMed |
| 438,809 | Trazodone, a central serotonin antagonist and agonist. | J Neural Transm | 1979 | https://conductscience.org/library/papers/438809 | PubMed |
| 160,509 | Evidence for a receptor supersensitivity following impairment of central serotoninergic activity in the rabbit. | Naunyn Schmiedebergs Arch Pharmacol | 1979 | https://conductscience.org/library/papers/160509 | PubMed |
| 108,704 | Quipazine-induced stimulus control in the rat. | Psychopharmacology (Berl) | 1979 | https://conductscience.org/library/papers/108704 | PubMed |
| 100,819 | The central antiserotonergic action of mianserin. | Psychopharmacology (Berl) | 1978 | https://conductscience.org/library/papers/100819 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6684
GET https://conductscience.org/api/papers/v1/6684/authors